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Abstract
Tuberous sclerosis complex is a genetic disorder, which affects many organs in the body manifesting spectrum of symptomatology. The 
severity of the disease can be gauged from the extent of involvement of a particular system. Since the disease runs a long course from 
its presentation at childhood till adulthood and hence the monitoring is very important to have some qualitative life. Other than the 
common symptomatology and a few laboratory tests, radiological investigations viz. ultrasound, color Doppler sonography, computed 
tomography and magnetic resonance imaging play a major role in follow-up for the management map road and associated complications. 
We present a case where a female child had a follow-up from the age of 8 years till 20 years of age. The follow-up and the management 
were designed mainly as per the radiological findings. The radiological findings have indicated the time for the patient to undergo 
surgical intervention in addition to the ongoing medical management.
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Tuberous sclerosis complex (TSC) is also known as Bournville’s disease or Epilola. This is a multisystem genetic disorder wrapping signs and symptoms of skin, 
brain, kidneys and other organs. This has manifested in the form 
of growth of many non-cancerous tumors (benign) in many parts 
of the body. It was discovered by French physician Bournville 
in 1880 [1]. TSC leads to significant health problems due to 
its multisystem involvement. The incidence is 1 in 6000 in the 
general population and there is no predilection for any sex.
CASE REPORT
An 8-year-old female first reported to the Pediatric Outpatient 
Department in 2001 for generalized seizures and mild degree 
of mental retardation. The child was having multiple reddish 
papillary lesions as facial angiofibromas in the nose, cheek 
and chin regions. Other diagnostic findings such as multiple 
dental enamel pittings, multiple hypomelanotic macules, 
shagreen patch and multiple ungual fibromas were present. 
She was admitted in pediatric intensive care unit (PICU) and 
anticonvulsant therapy was started to control the seizures 
along with other supportive therapies. The genetic workup and 
karyotyping has already confirmed the diagnosis of tuberous 
sclerosis before the patient came to this institute. Further 
radiological workup was planned to rule out progression 
of the disease and other systemic involvement. Contrast 
enhanced computed tomography (CECT) Head has shown a 
few bilateral sub ependymal and cortical tubers. X-ray chest 
was unremarkable and ultrasound (US) abdomen showed a few 
hamartoma of heterogeneous echogenicity in left kidney and 
inhomogeneity of echo texture in the right kidney.
The child was put on vigabatrin with the initial dose 
of 30 mg/kg/day divided in three doses and was gradually 
increased to 80 mg/kg/day. Though, the seizures were controlled 
but there was progressive increase in mental retardation, 
behavioral changes and learning problems. At 10 years of age, 
she complained of diplopia and repeat non-enhanced head CT 
(NCCT) head showed bilateral sub ependymal periventricular 
tubers and sub ependymal giant cell astrocytomas (GCA) 
on left side blocking the foramen of monro leading to 
hydrocephalus. The hydrocephalus was treated by placing 
the ventricular - peritoneal (VP) shunt by the neurosurgeon. 
Follow-up contrast enhanced magnetic resonance imaging 
(MRI) head, done after a fortnight, had shown considerable 
improvement (Fig. 1).
At the age of 12 years, the patient was investigated 
again for abdominal pain and found to have left sided renal 
angiomyolipoma (AML). At the age of 14 years, the left renal 
AML has become massive in size. The left kidney was non-
functioning as seen in excretory urography (Fig. 2). CECT 
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abdomen has shown a huge mass replacing the left kidney 
(Fig. 3). There was development of right sided AML as well but 
it was of small size. The child was kept in PICU for a fortnight 
due to multi-organ involvement and intractable seizures. 
She was managed with Midazolam continuous infusion with 
0.2 mg/kg bolus, followed by 0.1 mg/kg/h to control the 
seizures. She underwent left radical nephrectomy and was 
put on yearly follow-up. CECT, MRI and magnetic resonance 
angiography of head on this admission failed to show any new 
lesions.
In 2013 at the age of 20 years, she was again hospitalized 
with complaints of abdominal distension, increasing 
breathlessness and worsening neurological symptoms. Her 
blood urea was 56 mg/dl and serum creatinine was 2.3 mg/dl. 
X-ray abdomen showed right sided opaque abdomen displacing 
the gas shadows while ultrasonography abdomen showed a 
huge mass in the right renal region and its outline could not 
be delineated. CECT (Fig. 4) and MRI (Fig. 5) of abdomen 
have shown that the right kidney was replaced by a mass of in 
homogenous nature. Glomerular filtration rate has decreased 
considerably and the nephrology consultation was also taken. 
There was no venture advocated for the additional treatment 
Figure 1: Contrast enhanced T1W magnetic resonance 
imaging head (2004) axial section after a fortnight of the 
placement of ventricular - peritoneal (VP) shunt (white 
arrow). There is no hydrocephalus. VP shunt is seen in situ. 
The enhancing periventricular nodule is also seen in the 
image (black arrow)
Figure 2: Abdomen X-ray intravenous excretory urography 
(2007). There is no excretion seen on left side but the right 
kidney shows excretion with splaying of calyceal system 
(black arrow)
Figure 3: Contrast enhanced computed tomography 
abdomen (2007) axial section: There is huge mass replacing 
the left kidney (black arrow). The mass is predominantly of 
fat constituent with few soft tissue components suggestive 
of angiomyolipoma (AML). Right kidney also shows a few 
small AMLs (white arrow)
Figure 4: Contrast enhanced computed tomography 
abdomen (2013) axial section shows a large heterogenous 
mass suggestive of angiomyolipoma in right renal fossa 
(white star). Left renal fossa is empty because of earlier 
total nephrectomy
Figure 5: Magnetic resonance imaging abdomen (2013) 
axial section gradient image with fat sat shows the total 
replacement of right renal tissue by the fat and other 
components (white broad arrow). Left renal fossa is empty
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keeping in view of the acute on chronic renal failure situation. 
The breathlessness was treated symptomatically because of the 
underlying renal impairment. NCCT head has shown multiple 
calcified foci in the periventricular region. There was no 
hydrocephalus and the shunt could also be seen in the scan. The 
functional MRI was planned to earmark the tubers responsible 
for the seizures and to advise surgery if possible. At present, 
the patient is mainly under follow-up of both neurologist and 
nephrologists beside other problems.
DISCUSSION
TSC is a genetic disorder of multidisciplinary involvement 
with autosomal dominant inheritance. The quality of life is 
highly affected by this disease because of so many progressive 
complications involving multiple organs. Mutations in two 
genes namely TSC1 and TSC2, which act as tumor suppressors, 
are responsible for various manifestations. TSC1 is related to 
the protein Hamartin on chromosome 9 (9q34) and TSC2 to the 
protein tuber in on chromosome 16 (16p13). The individuals 
of TSC are born with one mutated copy of TSC1 or TSC2. The 
second mutation must take place in lifetime for the development 
of some type of tumor in the body [2].
The patients usually develop symptoms before 10 years of 
age as in our case. The classical clinical Vogt’s triad (1908) 
of seizures, mental retardation and adenoma sebaceum is seen 
in 30% of the patients. This genetic disorder manifests by 
growth of numerous non-cancerous (benign) tumors in many 
parts of the body [3]. Cutaneous lesions are seen in 96% of 
the cases. Skin shows hypomelanotic macules, confetti lesions, 
facial angiofibromas, ungual fibromas, shagreen patches and 
forehead plaques. Facial angiofibromas are reddish papillary 
lesions on nose, cheek and chin and can be seen in 70% of 
cases. Pitting of dental enamel can be seen in almost 90% cases 
of TSC as compare to 9% in general population.
Neurological manifestations may be in the form of seizures 
(60%), mental retardation (40%), behavioral problems and 
brain tumors. There may be hyperactivity or aggression and 
attention deficit disorders. 80% of the cases show calcification 
which is not common in childhood. Subependymal nodules 
and GCA can cause various complications even blocking the 
CSF flow leading to hydrocephalus [4]. The peak incidence is 
from 8 to 18 years of age. Grey and white matter junctional 
lesions displace normal cortical tissue leading to abnormalities. 
10-15% of subependymal nodules may convert into GCA. The 
heart, lungs, kidneys, eyes and bones are other organs which can 
be affected by this order and include cardiac rhabdomyomas, 
retinal phakomas and lymphangioleiomyomatosis (LAM) 
causing serious lung complications. Renal cysts in childhood 
and AML in adults are the common kidney manifestations. 20% 
of all AML are from this entity. The complications are because 
of enormous size of the AML with internal bleeding. The lesion 
can be decreased in size by embolization by interventional 
radiological procedures. The complications have decreased 
considerably because of better and advanced management. The 
bone involvement is in the form of sclerosis of calvaria, spine, 
ribs, long bones, metacarpals, metatarsals and phalanges. The 
clinical diagnostic criteria of TSC are of great value [5] in the 
diagnosis (Table 1).
For the clinical diagnosis following parameters are 
considered:
•	 Definite	TSC:	Either	two	major	criteria	or	one	major	with	
two minor criteria
•	 Probable	TSC:	One	major	and	two	minor	criterion
•	 Possible	 TSC:	 Either	 one	 major	 or	 two	 or	 more	 minor	
criteria.
There is great role of radiological investigations in the 
management and follow-up of TSC. The plain radiograph of 
chest can reveal early changes in the lungs as these patients can 
have LAM. US examination picks up the detailed anatomy of 
the kidneys with the developing tumors or cysts. AML can be 
characterized as per their size, shape, outline and the extent. 
There is always need of yearly screening for the kidney lesions. 
Color Doppler sonography (CDS) can highlight the vascularity 
of the lesions. CT and MRI are the most sensitive imaging 
modalities for the diagnosis [6-9]. These further add to the 
information regarding the functional status of the organs after 
the contrast study. MRI is performed in the patient on 1-3 years 
basis irrespective of the patient symptoms. MRI is useful in 
picking up the cortical and sub-cortical tubers as it has got the 
property of tissue characterization. These are hyper intense on 
T1W and hypo intense in younger children. In older children, 
these tubers become isointense on T1W and hyper intense on 
T2W [10-12]. Only 10% of the lesions show enhancement. On 
the other hand, CT is good for elaborating renal lesions and 
calcification. AML shows hyper intensity on T1W images 
Table 1: Clinical diagnostic criteria for TSC
Major features Minor features
Hypomelanotic macules (>3) “Confetti” skin
Angiofibroma (>3) or 
forehead plaque
Dental enamel pits (>3)
Ungual fibromas (>2) Intraoral fibromas (>2)
Shagreen patch or multiple 
collagenomas
Retinal achromic patch
Multiple retinal hamartomas Multiple renal cysts
Cortical dysplasias (>3) Nonrenal hamartomas
Subependymal nodules (>2)
Subependymal GCA (>2)
Cardiac rhabdomyoma
LAM
AML (>2)
GCA: Giant cell astrocytomas, 
LAM: Lymphangioleiomatosis, AML: Angiomyolipomas, 
TSC: Tuberous sclerosis complex
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and these lesions show signal loss after fat suppression 
sequences [13,14].
Management depends upon the involvement of the particular 
system. Primary aim is to control seizures and treatment 
guidelines are similar as that of epilepsy. The other new drugs 
used for seizures are topiramate, lamotrigine, oxcarbazepine 
and levetiracetam, but unfortunately pharmacoresistance is 
quite common. The alternative treatment for the medical drug 
resistance cases is in the form of ketogenic/low glycine diet, 
vagus nerve stimulation and selective surgery for the responsible 
cortical tubers seen in functional MRI [15]. Supportive treatment 
is essential part of the management to improve the quality-of-
life [16]. 40% of the patients die by 35 years of age. The drug 
like sirolimus (rapamycin) has been used with a few benefits; 
however, in our case these drugs were not used.
CONCLUSION
The patients of TSC have got multi-system involvement with 
progressive course leading to wide spectrum of symptoms. The 
management has to be tailored in that fashion along with genetic 
screening and counseling. In addition to the plain radiography, 
the US, CDS, CT and MRI are invaluable tools in the diagnosis 
and management guidance. As in the present case, long-term 
follow-up by radiological investigations helped in the patient 
management.
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